Search
for
Sort by
Research 61–90 of 1000+
- Advances in Nanotechnology-Based Topical Delivery Systems for Skincare Applications
- SKIN MANIFESTATIONS OF RHEUMATOLOGICAL DISEASES
- Sclero-Atrophic Reaction after Botulinum Toxin Injection
- Distinctive histopathologic findings in linear morphea (<i>en coup de sabre</i>) alopecia
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Becker's Nevus with Ipsilateral Breast Hypoplasia: Improvement with Spironolactone
- Hirsutism
- Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study
- Search Advances in Lip Skin Biology and Anti-Aging Strategies
- Hair Disorders
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Hypothyroidism in Dogs
- Minimizing injury to the donor area in follicular unit extraction (FUE) harvesting
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Dermatoses of pregnancy
- Theoretical considerations in laser hair removal
- From neural crest cells to melanocytes: cellular plasticity during development and beyond
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Disrupted Ectodermal Organ Morphogenesis in Mice with a Conditional Histone Deacetylase 1, 2 Deletion in the Epidermis
- A Clinical Approach to Severe Insulin Resistance
- Thyroid hormone action on skin.
- Problems and Solutions for Platelet-Rich Plasma in Facial Rejuvenation: A Systematic Review
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- A clinical and histopathological study of cicatricial alopecia
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists
- Cosmetic surgery in men
- Effectiveness of Radiofrequency Microneedling in the Treatment of Dermatological Conditions: A Systematic Review
- Melanocytes and Vitiligo (and Hair Graying)
- Dermatological drugs, topical agents, and cosmetics
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system